Folate Intake and Ovarian Cancer Risk among Women with Endometriosis: A Case-Control Study from the Ovarian Cancer Association Consortium.
Journal Information
Full Title: Cancer Epidemiol Biomarkers Prev
Abbreviation: Cancer Epidemiol Biomarkers Prev
Country: Unknown
Publisher: Unknown
Language: N/A
Publication Details
Related Papers from Same Journal
Transparency Score
Transparency Indicators
Click on green indicators to view evidence textCore Indicators
"Authors' Disclosures K.L. Terry reports grants from the NIC and grants from Congressionally Directed Medical Research Program during the conduct of the study. B. Qin reports grants from NIH during the conduct of the study. F. Modugno reports grants from National Science Foundation and from the Department of Defense during the conduct of the study. H.A. Risch reports grants from NCI, NIH during the conduct of the study. P.M. Webb reports grants from U.S. Army Medical Research and Materiel Command, National Health and Medical Research Council of Australia, and Cancer Councils of New South Wales, Victoria, Queensland, South Australia and Tasmania, Cancer Foundation of Western Australia during the conduct of the study; grants from AstraZeneca and personal fees from AstraZeneca outside the submitted work. No disclosures were reported by the other authors."
"OCAC was funded by a grant from the Ovarian Cancer Research Fund (OCRF) and we are also grateful to the family and friends of Kathryn Sladek Smith for their generous support of the Ovarian Cancer Association Consortium through their donations to the OCRF. The OCAC OncoArray genotyping project was funded through grants from the NIH (CA1 × 01HG007491-01, U19-CA148112, and R01-CA149429), NIH (R01-CA058598; to M.T. Goodman), Canadian Institutes of Health Research (MOP-86727), and the OCRF. The COGS project was funded through a European Commission's Seventh Framework Programme grant (agreement number 223175—HEALTH-F2-2009-223175) and in part by the U.S. National Cancer Institute GAME-ON Post-GWAS Initiative (U19-CA148112). This study made use of data generated by the Wellcome Trust Case Control consortium that was funded by the Wellcome Trust under award 076113. Individual studies were funded by AUS: U.S. Army Medical Research and Materiel Command (DAMD17-01-1-0729; to P.M. Webb) and National Health and Medical Research Council of Australia (199600, 400413, 400281, and 1173346; to P.M. Webb); DOV: NIH R01-CA112523 and R01-CA87538 (to J.A. Doherty); HAW: NIH (R01-CA58598, N01-CN-55424, and N01-PC-67001; to M.T. Goodman); HOP: University of Pittsburgh School of Medicine Dean's Faculty Advancement Award (F. Modugno), Department of Defense (DAMD17–02–1-0669; to F. Modugno) and NCI (K07-CA080668, R01-CA95023, P50-CA159981, MO1-RR000056, and R01-CA126841; to F. Modugno); LAC: NIH (P01CA17054, P30CA14089, N01PC67010, and N01CN025403; to A.H. Wu), NIH (R01CA61132, R03CA113148, and R03CA115195), and California Cancer Research Program (00-01389V-20170; 2II0200; to A.H. Wu); MAC: National Institutes of Health (R01-CA122443, P30-CA15083, P50-CA136393 to E.L. Goode); Mayo Foundation; Minnesota Ovarian Cancer Alliance; Fred C. and Katherine B. Andersen Foundation (to E.L. Goode); Fraternal Order of Eagles; MAY: National Institutes of Health (R01-CA122443, P30-CA15083, P50-CA136393 to E.L. Goode); Mayo Foundation; Minnesota Ovarian Cancer Alliance; Fred C. and Katherine B. Andersen Foundation (to E.L. Goode); NCO: National Institutes of Health (R01-CA76016) and the Department of Defense (DAMD17-02-1-0666); NEC: National Institutes of Health R01-CA54419 and P50-CA105009 and Department of Defense W81XWH-10-1-02802 (to K.L. Terry); NJO: National Cancer Institute (NIH-K07 CA095666, R01-CA83918, NIH-K22-CA138563, and P30-CA072720; to E.V. Bandera) and the Rutgers Cancer Institute of New Jersey (to E.V. Bandera); NTH: Radboud University Medical Centre; OPL: National Health and Medical Research Council (NHMRC) of Australia (APP1025142, APP1120431 to P.M. Webb) and Brisbane Women's Club (to P.M. Webb); SEA: Cancer Research UK (C490/A10119 C490/A10124); UK National Institute for Health Research Biomedical Research Centres at the University of Cambridge; TBO: National Institutes of Health (R01-CA106414-A2), American Cancer Society (CRTG-00-196-01-CCE), Department of Defense (DAMD17-98-1-8659), Celma Mastry Ovarian Cancer Foundation; TOR: NIH grants R01 CA063678 and R01 CA063682 (to H.A. Risch); UCI: NIH R01-CA058860 and the Lon V Smith Foundation grant LVS-39420; UKO: The UKOPS study was funded by The Eve Appeal (The Oak Foundation) with salary contribution to Usha Menon and Aleksandra Gentry-Maharaj through MRC core funding (MC_UU_00004/01). The pooling and harmonizing of dietary information was supported by the Department of Defense Congressionally Directed Medical Research Programs (grant number W81XSH-16-2-0010). Funding was also provided by the National Science Foundation (DGE-2217399-Modugno; to F. Modugno). The views expressed are those of the authors and do not necessarily reflect the views of the National Science Foundation."
Additional Indicators
Assessment Info
Tool: rtransparent
OST Version: N/A
Last Updated: Aug 05, 2025